Kalaris Therapeutics, Inc.

Siren, L.L.C. KLRS
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
435,798
Value ($000)
1,774
Weight
0.0%
2025 Q1 - 2026 Q2 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).